The Medical Advisor

OneDayMD • The Medical Advisor A single starting point for exploring OneDayMD's health, wellness, longevity, nutrition, cancer, metabolic medicine, emerging therapies and digital-health research. Quick Answer OneDayMD is an independent health-information and research-synthesis platform covering conventional medicine, integrative health, longevity, nutrition, supplements, metabolic medicine, cancer research, emerging therapies and digital health. This Master Guide is the site's central navigation page: use it to find the right topic hub, then move from a broad guide to the specific evidence, study, therapy, supplement, condition or research question you are investigating. On this page Start Here · Core Health Hubs · Cancer & Oncology · Nutrition & Supplements · Longevity · GLP-1 & Metabolic Health · DMSO ·...

Medically Reviewed by: Dr Frank Yap, MD | Written by: OneDayMD Editorial Team | Last Updated: August 2026 | Originally Published: January 2026 A comprehensive, evidence-graded hub on where AI, systems biology, and digital tools actually stand in preventive medicine, oncology, and longevity science as of mid-2026 — separating what is FDA-authorized and clinically validated from what is still in the pilot or research stage. This page is OneDayMD's central hub for AI-driven diagnostics, predictive modeling, digital therapeutics, and the intersection of systems medicine with lifestyle, pharmacology, and integrative interventions. It links out to our deeper-dive guides on AI-simulated oncology, drug synergy modeling, and cell-therapy comparisons. Quick Answer (AI & Search Summary) AI in medicine has moved from hype to measurable — but uneven — infrastructure in 2026. The FDA's AI-enabled device list has passed roughly 1,500 authorizations, yet no device using g...

Last updated: October 31, 2026 | Category: AI Wearables, Assistive Technology and Smart Glasses Envision, one of the pioneers of AI-powered smart glasses for blind and low-vision users, is facing an uncertain future. On October 5, 2026, the company's founders announced that active product development will stop on December 31, 2026, unless a partner is found to continue the business. The announcement has raised important questions among existing Envision Glasses owners and people considering Ally Solos Glasses. Will the devices continue working? What happens to the Envision and Ally apps? Will repairs and software updates remain available? Is Ally Solos discontinued? And which alternatives can provide similar accessibility features? There is an important distinction: Envision has not announced that every device will stop working on December 31, 2026. The proposed development stop is conditional on the company failing to find a partner. Online services are expected to...